Table S1 from Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study
Authors:
- Andrea Wang-GillamAWAndrea Wang-Gillam
- Kian-Huat LimKLKian-Huat Lim
- Robert McWilliamsRMRobert McWilliams
- Rama SureshRSRama Suresh
- Albert C. LockhartALAlbert C. Lockhart
- Amberly BrownABAmberly Brown
- Marcus BredenMBMarcus Breden
- Jad I. BelleJBJad I. Belle
- John HerndonJHJohn Herndon
- Savannah J. BognerSBSavannah J. Bogner
- Katrina PedersenKPKatrina Pedersen
- Benjamin TanBTBenjamin Tan
Open Access
- 25 November 2025
- other
- Published by American Association for Cancer Research (AACR)